vaginal smears

Summary

Summary: Collection of pooled secretions of the posterior vaginal fornix for cytologic examination.

Top Publications

  1. ncbi The psychosocial burden of human papillomavirus related disease and screening interventions
    M Pirotta
    University of Melbourne, Primary Care Research Unit, Department of General Practice, Victoria, Australia
    Sex Transm Infect 85:508-13. 2009
  2. ncbi Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial
    Guglielmo Ronco
    Centre for Cancer Prevention, Turin, Italy
    Lancet Oncol 11:249-57. 2010
  3. ncbi Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
    J Paavonen
    Department of Obstetrics and Gynaecology, University of Helsinki, Helsinki, Finland
    Lancet 374:301-14. 2009
  4. ncbi Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial
    Dorien C Rijkaart
    Department of Pathology, VU University Medical Centre, Amsterdam, Netherlands
    Lancet Oncol 13:78-88. 2012
  5. ncbi Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement
    Virginia A Moyer
    U S Preventive Services Task Force, Rockville, Maryland, USA
    Ann Intern Med 156:880-91, W312. 2012
  6. ncbi The 2001 Bethesda System: terminology for reporting results of cervical cytology
    Diane Solomon
    EPN Room 2130, 6130 Executive Blvd, Bethesda, MD 20892, USA
    JAMA 287:2114-9. 2002
  7. pmc American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer
    Debbie Saslow
    Cancer Control Science Department, American Cancer Society, Atlanta, GA 30303, USA
    CA Cancer J Clin 62:147-72. 2012
  8. ncbi Human papillomavirus and Papanicolaou tests to screen for cervical cancer
    Pontus Naucler
    Department of Medical Microbiology, Malmo University Hospital, Lund University, Malmo, Sweden
    N Engl J Med 357:1589-97. 2007
  9. pmc Human papillomavirus testing in the prevention of cervical cancer
    Mark Schiffman
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
    J Natl Cancer Inst 103:368-83. 2011
  10. pmc HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study
    Murat Gok
    Department of Pathology, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, Netherlands
    BMJ 340:c1040. 2010

Research Grants

  1. STRESS BIOLOGY, RACE/ETHNICITY & INFECTION IN PREGNANCY
    Pathik Wadhwa; Fiscal Year: 2006
  2. Mentored Investigator Award in Women's Health
    Lori Boardman; Fiscal Year: 2005
  3. Reversal of Infertility in Ovarian Failure
    Ayman Al Hendy; Fiscal Year: 2006
  4. OBESITY AND INFERTILITY IN THE LETHAL YELLOW MOUSE
    Maureen Diggins; Fiscal Year: 1991
  5. BRAIN MACROPHAGES AND REPRODUCTIVE AGING
    Frederick Naftolin; Fiscal Year: 2002
  6. STUDY OF VAGINAL DANAZOL ON ENDOMETRIOSIS
    John Ziemniak; Fiscal Year: 1999
  7. REPEAT MAMMOGRAPHY AMONG LOW INCOME AND MINORITY WOMEN
    Maria Fernandez; Fiscal Year: 2003
  8. Liver Cancer Control Among North American Chinese
    Victoria Taylor; Fiscal Year: 2006
  9. Hepatitis B ESL Education for Chinese
    Victoria Taylor; Fiscal Year: 2009
  10. Cervical Cancer Control in Vietnamese Women
    Victoria Taylor; Fiscal Year: 2007

Detail Information

Publications271 found, 100 shown here

  1. ncbi The psychosocial burden of human papillomavirus related disease and screening interventions
    M Pirotta
    University of Melbourne, Primary Care Research Unit, Department of General Practice, Victoria, Australia
    Sex Transm Infect 85:508-13. 2009
    ....
  2. ncbi Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial
    Guglielmo Ronco
    Centre for Cancer Prevention, Turin, Italy
    Lancet Oncol 11:249-57. 2010
    ..We assessed the efficacy of cervical-cancer screening policies that are based on HPV testing...
  3. ncbi Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
    J Paavonen
    Department of Obstetrics and Gynaecology, University of Helsinki, Helsinki, Finland
    Lancet 374:301-14. 2009
    ..We now assess the vaccine efficacy in the final event-driven analysis...
  4. ncbi Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial
    Dorien C Rijkaart
    Department of Pathology, VU University Medical Centre, Amsterdam, Netherlands
    Lancet Oncol 13:78-88. 2012
    ..The aim of this study was to assess whether HPV DNA testing in the first screen decreases detection of cervical intraepithelial neoplasia (CIN) grade 3 or worse, CIN grade 2 or worse, and cervical cancer in the second screening...
  5. ncbi Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement
    Virginia A Moyer
    U S Preventive Services Task Force, Rockville, Maryland, USA
    Ann Intern Med 156:880-91, W312. 2012
    ..Update of the 2003 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for cervical cancer...
  6. ncbi The 2001 Bethesda System: terminology for reporting results of cervical cytology
    Diane Solomon
    EPN Room 2130, 6130 Executive Blvd, Bethesda, MD 20892, USA
    JAMA 287:2114-9. 2002
    ..A primary objective was to develop a new approach to broaden participation in the consensus process...
  7. pmc American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer
    Debbie Saslow
    Cancer Control Science Department, American Cancer Society, Atlanta, GA 30303, USA
    CA Cancer J Clin 62:147-72. 2012
    ....
  8. ncbi Human papillomavirus and Papanicolaou tests to screen for cervical cancer
    Pontus Naucler
    Department of Medical Microbiology, Malmo University Hospital, Lund University, Malmo, Sweden
    N Engl J Med 357:1589-97. 2007
    ....
  9. pmc Human papillomavirus testing in the prevention of cervical cancer
    Mark Schiffman
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
    J Natl Cancer Inst 103:368-83. 2011
    ..The greatest potential for reduction in cervical cancer rates from HPV screening is in low-resource regions that can implement infrequent rounds of low-cost HPV testing and treatment...
  10. pmc HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study
    Murat Gok
    Department of Pathology, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, Netherlands
    BMJ 340:c1040. 2010
    ..To determine whether offering self sampling of cervicovaginal material for high risk human papillomavirus (HPV) testing is an effective screening method for women who do not attend regular cervical screening programmes...
  11. ncbi Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study
    Margaret R E McCredie
    Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand
    Lancet Oncol 9:425-34. 2008
    ..We aimed to estimate the long-term risk of invasive cancer in these two groups of women. A judicial inquiry referred for independent clinical review in 1988 all women for whom there remained doubt about the adequacy of their management...
  12. ncbi The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice
    Michelle J Khan
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, Rm 7074, Rockville, MD 20852, USA
    J Natl Cancer Inst 97:1072-9. 2005
    ....
  13. pmc Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence
    Susanne K Kjær
    Department of Viruses, Hormones and Cancer, Institute of Cancer Epidemiology, Danish Cancer Society, Strandboulevarden 49, DK 2100 Copenhagen, Denmark
    J Natl Cancer Inst 102:1478-88. 2010
    ..Persistent HPV infection could also be a useful screening marker. We estimated the long-term risk of high-grade CIN after one-time detection of high-risk HPV DNA and after persistent infection with individual high-risk HPV types...
  14. pmc Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study
    Joakim Dillner
    Lund University, Medical Microbiology, University Hospital MAS, 205 02 Malmo, Sweden
    BMJ 337:a1754. 2008
    ..To obtain large scale and generalisable data on the long term predictive value of cytology and human papillomavirus (HPV) testing for development of cervical intraepithelial neoplasia grade 3 or cancer (CIN3+)...
  15. pmc Inequalities in reported use of breast and cervical screening in Great Britain: analysis of cross sectional survey data
    Kath Moser
    Cancer Epidemiology Unit, University of Oxford, Oxford OX3 7LF
    BMJ 338:b2025. 2009
    ..To investigate the relation between women's reported use of breast and cervical screening and sociodemographic characteristics...
  16. pmc Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population
    Nicolas Wentzensen
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland 20852, USA
    Clin Cancer Res 18:4154-62. 2012
    ..However, the specificity of HPV DNA testing is limited, requiring additional, more disease-specific markers for efficient screening approaches...
  17. pmc High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up
    L L Villa
    Ludwig Institute for Cancer Research, R Prof Antonio Prudente 109, 01509 010 Sao Paulo, SP, Brazil
    Br J Cancer 95:1459-66. 2006
    ..This duration supports vaccination of adolescents and young adults, which is expected to greatly reduce the burden of cervical and genital cancers, precancerous dysplasia, and genital warts...
  18. ncbi Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting
    Maarit Leinonen
    Mass Screening Registry, Finnish Cancer Registry, Pieni Roobertinkatu 9, FI 00130 Helsinki, Finland
    J Natl Cancer Inst 101:1612-23. 2009
    ..We compared the age-specific performance of primary HPV DNA screening with that of conventional cytology screening in the setting of an organized population-based cervical cancer screening program in Finland...
  19. ncbi Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial
    Eduardo Lazcano-Ponce
    Centro de Investigacion en Salud Poblacional, Instituto Nacional de Salud Publica, Cuernavaca, Morelos, Mexico
    Lancet 378:1868-73. 2011
    ..We aimed to establish the relative sensitivity and positive predictive value for HPV screening of vaginal samples self-collected at home as compared with clinic-based cervical cytology...
  20. pmc Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections
    Ana Cecilia Rodriguez
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, EPS, Rm 5032, Rockville, MD 20852, USA
    J Natl Cancer Inst 100:513-7. 2008
    ..These findings suggest that the medical community should emphasize persistence of cervical HPV infection, not single-time detection of HPV, in management strategies and health messages...
  21. ncbi Contextual analysis of breast and cervical cancer screening and factors associated with health care access among United States women, 2002
    Steven S Coughlin
    Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Soc Sci Med 66:260-75. 2008
    ..A significant interaction was also observed between the percentage of county female population who were Hispanic and the percentage who were non-Hispanic Black...
  22. pmc Pooled analysis of a self-sampling HPV DNA Test as a cervical cancer primary screening method
    Fang Hui Zhao
    Department of Epidemiology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People s Republic of China
    J Natl Cancer Inst 104:178-88. 2012
    ....
  23. pmc Psychosocial predictors of adherence to risk-appropriate cervical cancer screening guidelines: a cross sectional study of women in Ohio Appalachia participating in the Community Awareness Resources and Education (CARE) project
    Electra D Paskett
    College of Public Health, The Ohio State University, Columbus, OH 43210, USA
    Prev Med 50:74-80. 2010
    ..e., guidelines that specify screening intervals based upon a woman's individual risk of developing cervical cancer)...
  24. pmc Sociodemographic gradients in breast and cervical cancer screening in Korea: the Korean National Cancer Screening Survey (KNCSS) 2005-2009
    Mi Jin Park
    National Cancer Control Institute, National Cancer Center, 111 Jungbalsan ro, Ilsandong gu, Goyang si, Gyeonggi do 410 769, Korea
    BMC Cancer 11:257. 2011
    ..1%) and the third highest was cervical cancer (76.1%). Despite overall increases in the screening rate, disparities in breast and cervical cancer screening, based on sociodemographic characteristics, still exist...
  25. ncbi Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study
    C B Woodman
    Centre for Cancer Epidemiology, University of Manchester, Withington, M20 4QL, Manchester, UK
    Lancet 357:1831-6. 2001
    ..We studied the natural history of incident cervical HPV infection and its relation to the development of CIN...
  26. pmc Cervical cancer prevention: new tools and old barriers
    Isabel C Scarinci
    Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, Alabama 35294 4410, USA
    Cancer 116:2531-42. 2010
    ..The goal was to inform future research and outreach efforts to reduce the burden of cervical cancer in underserved populations...
  27. ncbi 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests
    Thomas C Wright
    Department of Pathology, College of Physicians and Surgeons of Columbia University, New York, NY 10032, USA
    Am J Obstet Gynecol 197:346-55. 2007
    ..The 2004 Interim Guidance for HPV testing as an adjunct to cervical cytology for screening in women 30 years of age and older was formally adopted with only very minor modifications...
  28. ncbi Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey
    Maria Hewitt
    National Cancer Policy Board, Institute of Medicine, National Academy of Sciences, Washington, DC 20001, USA
    Prev Med 39:270-8. 2004
    ..Cervical cancer screening is not fully utilized among all groups of women in the United States, especially women without access to health care and older women...
  29. pmc HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial
    A Szarewski
    Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK
    Br J Cancer 104:915-20. 2011
    ....
  30. pmc Prevalence of HPV high and low risk types in cervical samples from the Italian general population: a population based study
    Paolo Giorgi Rossi
    Laziosanità Agency for Public Health, Lazio Region, Via di S, Costanza 53, 00198 Rome, Italy
    BMC Infect Dis 10:214. 2010
    ..This multicenter study describes the type-specific prevalence of HPV infection in the general population from central and southern Italy, comparing the data with previously published Italian studies...
  31. pmc Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia
    Groesbeck P Parham
    School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA, and University Teaching Hospital, Lusaka, Zambia
    Gynecol Oncol 103:1017-22. 2006
    ..We evaluated the prevalence and predictors of cervical squamous intraepithelial lesions (SIL) among HIV-infected women in Zambia...
  32. pmc Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection
    Rebecca M Brotman
    Institute for Genome Sciences and Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    J Infect Dis 202:1907-15. 2010
    ..We sought to assess the relationship between bacterial vaginosis (BV) assessed by Gram stain and incident trichomonal, gonococcal, and/or chlamydial genital infection...
  33. ncbi HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial
    Henry C Kitchener
    School of Cancer and Imaging Sciences, University of Manchester, Manchester, UK
    Lancet Oncol 10:672-82. 2009
    ....
  34. pmc Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions
    J W Sellors
    Health Services Delivery Research Unit, Father Sean O Sullivan Research Centre, St Joseph s Hospital, Hamilton, Ont
    CMAJ 163:513-8. 2000
    ..We determined and compared the test characteristics of testing for HPV with samples obtained by patients and with samples obtained by their physicians...
  35. ncbi Knowledge about human papillomavirus among adolescents
    D L Dell
    Duke University Medical Center, Durham, North Carolina, USA
    Obstet Gynecol 96:653-6. 2000
    ..To assess knowledge of human papillomavirus (HPV) among high school-aged adolescents...
  36. ncbi Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia
    N F Schlecht
    Department of Oncology, McGill University, 546 Pine Ave W, Montreal, Quebec, Canada H2W1S6
    JAMA 286:3106-14. 2001
    ....
  37. ncbi Impact of the National Breast and Cervical Cancer Early Detection Program on mammography and Pap test utilization among white, Hispanic, and African American women: 1996-2000
    E Kathleen Adams
    Department of Health Policy and Management, Rollins School of Public Health, Atlanta, Georgia 30322, USA
    Cancer 109:348-58. 2007
    ..Cancer 2007. (c) 2006 American Cancer Society...
  38. ncbi Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis
    Mark E Sherman
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Natl Cancer Inst 95:46-52. 2003
    ..We evaluated whether simultaneous screening with a Pap test and human papillomavirus (HPV) testing is useful for assessing the risk for cervical intraepithelial neoplasia (CIN) 3 or cervical cancer...
  39. ncbi The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period
    Susanne Kjaer
    Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark
    Cancer Res 66:10630-6. 2006
    ..These results indicate that even a single positive HPV test in cytologically negative women is substantially predictive of high-grade CIN and suggest that HC2 testing can help stratify women into different risk categories...
  40. ncbi Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis
    Patrick Petignat
    Senology and Gynaecologic Oncology Unit, Geneva University Hospitals, 1211 Geneva 14, Switzerland
    Gynecol Oncol 105:530-5. 2007
    ..To compare the detection rate of genital human papillomavirus (HPV) infection in self- and physician-obtained samples...
  41. pmc Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice
    Hormuzd A Katki
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, DHHS, Bethesda, MD 20882, USA
    Lancet Oncol 12:663-72. 2011
    ....
  42. ncbi p16/ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study
    Dietmar Schmidt
    Institute of Pathology, Mannheim, Germany
    Cancer Cytopathol 119:158-66. 2011
    ....
  43. pmc Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis
    G S Ogilvie
    Department of Family Practice, STD AIDS Control, University of British Columbia Centre for Disease Control, 655 West 12th Avenue, Vancouver, BC, Canada V5Z 4R4
    Sex Transm Infect 81:207-12. 2005
    ....
  44. ncbi Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia
    Marc Arbyn
    European Network for Cervical Cancer Screening and Unit for Evaluation of Cancer Screening Programmes, Scientific Institute of Public Health, Brussels, Belgium
    J Natl Cancer Inst 96:280-93. 2004
    ..We performed a meta-analysis to assess the accuracy of human papillomavirus (HPV) DNA testing as an alternative to repeat cytology in women who had equivocal results on a previous Pap smear...
  45. ncbi Validation of recall of breast and cervical cancer screening by women in an ethnically diverse population
    Stephen J McPhee
    Vietnamese Community Health Promotion Project, Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, 94102, USA
    Prev Med 35:463-73. 2002
    ....
  46. pmc Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial
    A Sargent
    Division of Cancer Studies and Imaging, University of Manchester, Hathersage Road, Manchester M13 0JH, UK
    Br J Cancer 98:1704-9. 2008
    ..In the absence of broader cross-protection, the large majority of low-grade and many high-grade abnormalities may still occur in sexually active vaccinated women...
  47. ncbi 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities
    Thomas C Wright
    Department of Pathology, College of Physicians and Surgeons of Columbia University, Room 16 404, P and S Bldg, 630 W 168th St, New York, NY 10032, USA
    JAMA 287:2120-9. 2002
    ..To provide evidence-based consensus guidelines for the management of women with cervical cytological abnormalities and cervical cancer precursors...
  48. ncbi Factors related to poor practice of Pap smear screening among secondary school teachers in Malaysia
    Fauziah Abdullah
    Centre for Population Health CePH, Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Malaysia
    Asian Pac J Cancer Prev 12:1347-52. 2011
    ..Yet its importance has been overlooked by beneficiaries in Malaysia. This underlines the need to identify the prevalence of Pap smear practice and influencing factors towards the practice among educated working women...
  49. ncbi Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer
    Marie Helene Mayrand
    Department of Oncology and Epidemiology and Biostatistics, McGill University, Montreal, Canada
    N Engl J Med 357:1579-88. 2007
    ..To determine whether testing for DNA of oncogenic human papillomaviruses (HPV) is superior to the Papanicolaou (Pap) test for cervical-cancer screening, we conducted a randomized trial comparing the two methods...
  50. ncbi Human papillomavirus prevalence and type distribution in 3603 HIV-positive and HIV-negative women in the general population of Tanzania: the PROTECT study
    Myassa Dartell
    Department of International Health, Public Health Institute, University of Copenhagen, Copenhagen, Denmark
    Sex Transm Dis 39:201-8. 2012
    ....
  51. ncbi Enhancement of the cervical cancer screening program in Malaysia: a qualitative study
    Fauziah Abdullah
    Centre for Population Health, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
    Asian Pac J Cancer Prev 11:1359-66. 2010
    ..The aim of this study is to determine providers perceptives on the program and the feasibility of practicing an organized cervical screening program in Malaysia...
  52. pmc Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results
    Matthew P Stevens
    Department of Microbiology, The Royal Women s Hospital, 132 Grattan Street, Carlton, Victoria 3053, Australia
    J Clin Microbiol 45:2130-7. 2007
    ..Both PCR-based HPV tests may be valuable in the management of care for women with underlying cervical abnormalities, in predicting treatment success, and in studying the clearance or acquisition of new infections...
  53. ncbi Urine HPV-DNA detection for cervical cancer screening: prospects and prejudices
    A Sehgal
    Division of Epidemiology and Biostatistics, Institute of Cytology and Preventive Oncology ICMR, Noida, India
    J Obstet Gynaecol 29:583-9. 2009
    ....
  54. ncbi HPV vaccine protein L1 predicts disease outcome of high-risk HPV+ early squamous dysplastic lesions
    Henrik Griesser
    Center of Pathology and Cytodiagnostics, Cologne, Germany
    Am J Clin Pathol 132:840-5. 2009
    ..L1- early dysplastic lesions, as nonproductive infections or precancerous lesions, have a high malignancy potential and close follow-up with colposcopy and histologic evaluation should be advised...
  55. ncbi Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden
    Bengt Andrae
    Department of Obstetrics and Gynecology, Gavle Hospital, S 801 87 Gävle, Sweden
    J Natl Cancer Inst 100:622-9. 2008
    ..Routine and comprehensive audits have been proposed as an ethically required component of screening. We performed a nationwide audit of the effectiveness of the Swedish cervical cancer screening program...
  56. ncbi Genotyping of human papillomavirus in triaging of low-grade cervical cytology
    Anna Söderlund-Strand
    World Health Organization HPV LabNet Global Reference Laboratory, Department of Clinical Microbiology, Skane University Hospital, Malmo, Sweden
    Am J Obstet Gynecol 205:145.e1-6. 2011
    ....
  57. pmc Knowledge of cervical cancer and screening practices of nurses at a regional hospital in Tanzania
    M Urasa
    Department of Women s and Children s Health, International Maternal and Child Health, Uppsala University, Sweden
    Afr Health Sci 11:48-57. 2011
    ..Precancerous lesions can be detected by Papanicolau smear screening. Nurses, being the largest group of health workers, have an important role in promotion of cervical cancer screening...
  58. pmc Clinical efficacy of human papillomavirus DNA detection in urine from patients with various cervical lesions
    Eun Seop Song
    Department of Obsterics and Gynecology, Inha University College of Medicine, Incheon, Korea
    J Korean Med Sci 22:99-104. 2007
    ....
  59. ncbi A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion
    Martyn Plummer
    International Agency for Research on Cancer, Lyon, France
    J Infect Dis 195:1582-9. 2007
    ..Most infections and associated lesions clear spontaneously. It is important to define the determinants and timing of clearance, so that viral persistence can be recognized and managed...
  60. ncbi Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis
    G M Clifford
    International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    Lancet 366:991-8. 2005
    ..We aimed to compare HPV-type distribution in representative samples of women from different world regions...
  61. ncbi Human papillomavirus and Papanicolaou tests screening interval recommendations in the United States
    Katherine B Roland
    Epidemiology and Applied Research Branch, Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Am J Obstet Gynecol 205:447.e1-8. 2011
    ..We assessed HPV test practices and Papanicolaou test screening interval recommendations of US providers...
  62. ncbi Cancer screening among the overweight and obese in Canada
    Rebecca S Mitchell
    Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
    Am J Prev Med 35:127-32. 2008
    ..S. studies have reported the reduced use of cancer screening among these subjects. We sought to analyze the relationship between overweight/obesity and cancer screening practices using population-based Canadian data...
  63. ncbi Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+ cytology-negative results
    Thomas C Wright
    Department of Pathology, Columbia University School of Medicine, New York, NY, USA
    Am J Clin Pathol 136:578-86. 2011
    ..5%) in HR-HPV- women. These analyses validate the 2006 American Society of Colposcopy and Cervical Pathology guidelines for HPV-16/HPV-18 genotyping, which recommend referral to colposcopy of HPV-16/HPV-18+ women with negative cytology...
  64. ncbi Self-collected samples for testing of oncogenic human papillomavirus: a systematic review
    Donna E Stewart
    University Health Network, Women s Health Program, Toronto ON
    J Obstet Gynaecol Can 29:817-28. 2007
    ..To investigate the role of self-sampling for human papillomavirus (HPV) testing as an alternative to cervical cancer screening by clinicians (i.e., Papanicolaou [Pap] test)...
  65. pmc Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study
    D Mesher
    Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Queen Mary University of London, Barts and the London School of Medicine and Dentistry, Charterhouse Square, LondonEC1 M 6BQ, UK
    Br J Cancer 102:1405-10. 2010
    ..Several studies have shown that testing for high-risk human papillomavirus (HPV) types results in an improved sensitivity for CIN2+, compared with cytology, although with a somewhat lower specificity...
  66. ncbi Decline in cervical cancer incidence and mortality in New South Wales in relation to control activities (Australia)
    Richard Taylor
    NSW Cervical Screening Program, Cumberland Hospital, Sydney, Australia
    Cancer Causes Control 17:299-306. 2006
    ..To examine time trends in cervical cancer incidence and mortality in NSW women aged yen20 years in relation to important health service initiatives and programs...
  67. ncbi Prognostic relevance of human papillomavirus L1 capsid protein detection within mild and moderate dysplastic lesions of the cervix uteri in combination with p16 biomarker
    Ralf Hilfrich
    Cytoimmun Diagnostics, Pirmasens, Germany
    Anal Quant Cytol Histol 30:78-82. 2008
    ..To proof the prognostic relevance of HPV L1 capsid protein detection on colposcopically-guided punch biopsies in combination with p16...
  68. ncbi Correlation of immunochemical detection of HPV L1 capsid protein in pap smears with regression of high-risk HPV positive mild/moderate dysplasia
    Henrik Griesser
    Department of Pathology, University of Wuerzburg, Wuerzburg, FRG
    Anal Quant Cytol Histol 26:241-5. 2004
    ..To immunostain Pap smears of high-risk (hr) HPV DNA-positive early squamous lesions for detecting HPV L1 protein...
  69. ncbi Cost of screening and treatment of cervical dyskaryosis in Germany
    K U Petry
    Frauenklinik im Klinikum der Stadt Wolfsburg, Wolfsburg, Germany
    Eur J Gynaecol Oncol 29:345-9. 2008
    ..The estimated average annual cost per patient was Euro 1,055, Euro 943 and Euro 3,174 for Pap III, IIID and IV, respectively. The cost of managing precancerous cervical lesions in Germany was shown to be high...
  70. ncbi Human papillomavirus triage of women with persistent borderline or mildly dyskaryotic smears: Comparison of costs and side effects of three alternative strategies
    Matejka Rebolj
    Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
    Int J Cancer 121:1529-35. 2007
    ..Therefore, we advocate including HPV testing before referring to colposcopy. Among the 3 HPV strategies, analysis of additional aspects favors implementation of immediate HPV testing...
  71. ncbi Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial
    Albertus G Siebers
    Department of Pathology, Radboud University Nijmegen Medical Centre, 824, PO Box 9101, 6500 HB Nijmegen, The Netherlands
    JAMA 302:1757-64. 2009
    ..Liquid-based cytology has been developed as an alternative for conventional cervical cytology. Despite numerous studies and systematic reviews, controversy remains about its diagnostic accuracy...
  72. ncbi Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the U.S. Preventive Services Task Force
    Evelyn P Whitlock
    Oregon Evidence Based Practice Center, Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon 97227, USA
    Ann Intern Med 155:687-97, W214-5. 2011
    ..Screening programs using conventional cytology have successfully reduced cervical cancer, but newer tests might enhance screening...
  73. pmc Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study
    I Wikstrom
    Department of Women s and Children s Health, Uppsala University, S751 85 Uppsala Sweden
    Br J Cancer 105:337-9. 2011
    ..Most women with cervical cancer have not participated in Pap-smear screening. Self-sampling of vaginal fluid in combination with high-risk HPV testing may be a method to increase the attendance rate...
  74. ncbi Self-sample HPV tests as an intervention for nonattendees of cervical cancer screening in Finland: a randomized trial
    Anni Virtanen
    Mass Screening Registry, Finnish Cancer Registry, Pieni Roobertinkatu 9, FI 00130 Helsinki, Finland
    Cancer Epidemiol Biomarkers Prev 20:1960-9. 2011
    ..We assessed the effects of self-sampling on attendance in the Finnish screening program...
  75. ncbi A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: extended follow up in the ARTISTIC trial
    Henry C Kitchener
    School of Cancer and enabling Sciences, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
    Eur J Cancer 47:864-71. 2011
    ..We wished to determine, through a further (third) round of screening in the ARTISTIC trial, the protection provided by a negative baseline HPV screen compared with that of cytology over a 6 year period...
  76. pmc HPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: results from the Sentinel Sites study
    R S Kelly
    Cancer Screening Evaluation Unit, Institute of Cancer Research, Richard Doll Building, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK
    Br J Cancer 105:983-8. 2011
    ..The aim of the present study was to study the impact of wider rollout of HPV triage for women with low-grade cytology on colposcopy referral and outcomes...
  77. ncbi Cervical cancer screening among urban immigrants by region of origin: a population-based cohort study
    Aisha K Lofters
    Department of Family and Community Medicine, University of Toronto, Toronto, Canada
    Prev Med 51:509-16. 2010
    ..We compared the prevalence of appropriate cervical cancer screening among screening-eligible immigrant women from major geographic regions of the world and native-born women...
  78. ncbi Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
    Mona Saraiya
    Epidemiology and Applied Research Branch, Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, 4770 Buford Hwy, Mailstop K 55, Atlanta, GA 30341, USA
    Arch Intern Med 170:977-85. 2010
    ..We assessed reported recommendations by US primary care physicians (PCPs) on screening intervals that incorporate HPV cotesting compared with Pap testing alone...
  79. ncbi Decomposing income-related inequality in cervical screening in 67 countries
    Brittany McKinnon
    Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Purvis Hall, Montreal, QC, H3A 1A2, Canada
    Int J Public Health 56:139-52. 2011
    ..We sought to identify important determinants contributing to inequality in cervical screening rates...
  80. pmc Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients
    K U Petry
    Abteilung für gynäkologische Onkologie MHH, Hannover, Germany
    Br J Cancer 88:1570-7. 2003
    ..These data show that HPV testing is of value for the detection or exclusion of prevalent CIN in a routine cervical cancer-screening setting and could be used for further risk classification of women for follow-up management...
  81. pmc Association of sexual abuse with incident high-risk human papillomavirus infection among young African-American women
    Gina M Wingood
    Department of Behavioral Sciences and Health Education, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA
    Sex Transm Dis 36:784-6. 2009
    ..Noticeably absent from the known risk factors for HPV infection is history of sexual abuse. The current study examined the association between sexual abuse and incident high-risk HPV among young adult black women...
  82. pmc An evaluation of liquid-based cytology and human papillomavirus testing within the UK cervical cancer screening programme
    C Sherlaw-Johnson
    Clinical Operational Research Unit, University College London, Department of Mathematics, University College London, Gower Street, London WC1E 6BT, UK
    Br J Cancer 91:84-91. 2004
    ..British Journal of Cancer (2004) 91, 84-91. doi:10.1038/sj.bjc.6601884 www.bjcancer.com Published online 25 May 2004..
  83. pmc Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology
    S M A Kulmala
    Department of Oral Pathology, Institute of Dentistry, University of Turku, Finland
    J Clin Pathol 59:513-7. 2006
    ....
  84. pmc High-risk HPV type-specific clearance rates in cervical screening
    N W J Bulkmans
    Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
    Br J Cancer 96:1419-24. 2007
    ..For the other hrHPV-positive women, it seems advisable to adopt a conservative management with a long waiting period, as hrHPV clearance is markedly higher after 18 months than after 6 months and the risk for >or=CIN3 is low...
  85. pmc Efficacy of patient letter reminders on cervical cancer screening: a meta-analysis
    D S Tseng
    Department of Medicine, University of Wisconsin, Madison, USA
    J Gen Intern Med 16:563-8. 2001
    ..To perform a meta-analysis on existing randomized controlled trials to investigate the efficacy of patient letter reminders on increasing cervical cancer screening using Pap smears...
  86. pmc Cancer-related risk indicators and preventive screening behaviors among lesbians and bisexual women
    S D Cochran
    Department of Epidemiology, School of Public Health, Center for Health Sciences, University of California, Los Angeles, Box 951772, Los Angeles, CA 90095 1772, USA
    Am J Public Health 91:591-7. 2001
    ..This study examined whether lesbians are at increased risk for certain cancers as a result of an accumulation of behavioral risk factors and difficulties in accessing health care...
  87. ncbi Human papillomavirus in cervical cancer
    F Xavier Bosch
    Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, Av Gran Via, s n km 2 7, 08907 L Hospitalet de Llobregat, Barcelona, Spain
    Curr Oncol Rep 4:175-83. 2002
    ....
  88. ncbi The role of education in the uptake of preventative health care: the case of cervical screening in Britain
    Ricardo Sabates
    Institute of Education, University of London, 20 Bedford Way, London WC1H 0AL, UK
    Soc Sci Med 62:2998-3010. 2006
    ..These findings enrich existing evidence on the socio-economic determinants of screening for cervical cancer and enable policy makers to better understand barriers to service uptake...
  89. ncbi Low rates of cervical cancer screening among urban immigrants: a population-based study in Ontario, Canada
    Aisha K Lofters
    Department of Family and Community Medicine, University of Toronto, Toronto, Canada
    Med Care 48:611-8. 2010
    ....
  90. ncbi Why many visible minority women in Canada do not participate in cervical cancer screening
    Ernest Amankwah
    Department of Community Health Sciences, Health Canada, First Nations and Inuit Health, Calgary, Alberta, Canada
    Ethn Health 14:337-49. 2009
    ..To determine a high-risk group of visible minority women in Canada who do not participate in cervical cancer screening and the reasons why they do not participate...
  91. ncbi Mass screening programmes and trends in cervical cancer in Finland and the Netherlands
    Maaike A van der Aa
    Comprehensive Cancer Centre, Stedendriehoek Twente, Enschede, The Netherlands
    Int J Cancer 122:1854-8. 2008
    ..Differences in risk factors might also play a role: the Netherlands has higher population density and higher percentages of immigrants and (female) smokers. The greater excess smear use in Finland might also have affected incidence...
  92. ncbi Oncogenic human papillomavirus infection and cervical lesions in aboriginal women of Nunavut, Canada
    S M Healey
    Health Protection Unit, Department of Health, Government of Nunavut, Iqaluit, Nunavut, Canada
    Sex Transm Dis 28:694-700. 2001
    ..CONCLUSION: The results of this study form the basis for further evaluation of the role that liquid-based cytology and HPV testing plays and will contribute to the strategy for cervical cancer prevention in Nunavut...
  93. pmc Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial
    Guglielmo Ronco
    Unit of Cancer Epidemiology, Centre for Cancer Prevention, Via S Francesco da Paola 31 10123 Turin, Italy
    BMJ 335:28. 2007
    ..To compare the accuracy of conventional cytology with liquid based cytology for primary screening of cervical cancer...
  94. ncbi Regression of low-grade squamous intra-epithelial lesions in young women
    Anna Barbara Moscicki
    Department of Pediatrics, University of California, San Francisco, CA, USA
    Lancet 364:1678-83. 2004
    ..The aim of this study was to assess the probability of low-grade squamous intra-epithelial lesion (LSIL) regression in young women, and to examine the factors associated with this regression...
  95. ncbi A randomised comparison of SurePath liquid-based cytology and conventional smear cytology in a colposcopy clinic setting
    P H Sykes
    Department of Obstetrics and Gynaecology, University of Otago, Christchurch, New Zealand
    BJOG 115:1375-81. 2008
    ..The objective of this study was to compare the sensitivity of cervical cytology using conventional smears and SurePath liquid-based cytology (LBC)...
  96. pmc Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group
    P D Sasieni
    Department of Mathematics, Statistics and Epidemiology, Imperial Cancer Research Fund, London, UK
    Br J Cancer 73:1001-5. 1996
    ..These data suggest that full adherence to current guidelines could perhaps have prevented another 1250 cases, but additional steps would have been required to prevent some of the 2300 remaining cases in women under the age of 70...
  97. ncbi Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy
    Alberto Agarossi
    Department of Obstetrics and Gynecology, Clinical Science Institute, L Sacco Hospital, University of Milan, Milan, Italy
    J Med Virol 81:529-35. 2009
    ..The findings of this study may contribute to reliable predictions on the potential efficacy of an HPV vaccine in clinical practice...
  98. ncbi HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer
    T C Wright
    Department of Pathology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    JAMA 283:81-6. 2000
    ..In many other regions of the world, there is only limited access to cervical cancer screening...
  99. ncbi Prevalence of type-specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self-collected specimens: Implications for vaginal self-collection
    Jerome L Belinson
    Department of Gynecology, The Cleveland Clinic Foundation, Cleveland, OH, USA
    Int J Cancer 127:1151-7. 2010
    ..The principal cause of the lower specificity of self-collected specimens is HR-HPV present solely in the vagina, which is not associated with > or = CIN 2...
  100. ncbi Chlamydia screening--Australia should strive to achieve what others have not
    Jane S Hocking
    Key Centre for Women s Health in Society, School of Population Health, University of Melbourne, Australia
    Med J Aust 188:106-8. 2008
    ..This experience places it in a strong position to design and implement an innovative chlamydia screening program to reduce chlamydia prevalence...
  101. ncbi Cervicovaginal cytological abnormalities in patients with human immunodeficiency virus infection, in relation to disease stage, CD4 cell count and viral load
    Adilha Misson Rua Micheletti
    Department of Special Pathology, Federal University of the Triângulo Mineiro UFTM School of Medicine, Uberaba MG, Brazil
    Diagn Cytopathol 37:164-9. 2009
    ..The viral load, therapeutic regimen and HIV subgroups (HIV-positive without therapy, HIV-positive with therapy, AIDS by immunological criteria and AIDS by clinical criteria) have not shown relationship with LSIL frequency, until now...

Research Grants67

  1. STRESS BIOLOGY, RACE/ETHNICITY & INFECTION IN PREGNANCY
    Pathik Wadhwa; Fiscal Year: 2006
    ..BV status will be assessed by Gram stained vaginal smears. Endocrine stress parameters will be assessed by measures of cortisol, corticotropin-releasing hormone (CRH), ..
  2. Mentored Investigator Award in Women's Health
    Lori Boardman; Fiscal Year: 2005
    ....
  3. Reversal of Infertility in Ovarian Failure
    Ayman Al Hendy; Fiscal Year: 2006
    ..We will assess cyclicity by vaginal smears and assay blood samples for estrogen, progesterone, testosterone, FSH, and LH levels to examine correction of ..
  4. OBESITY AND INFERTILITY IN THE LETHAL YELLOW MOUSE
    Maureen Diggins; Fiscal Year: 1991
    ..be sacrificed at 150, 180, 210 and 240 days of age during various stages of the estrous cycle (assessed by vaginal smears) and during pregnancy...
  5. BRAIN MACROPHAGES AND REPRODUCTIVE AGING
    Frederick Naftolin; Fiscal Year: 2002
    ..The reproductive cycles of normally aging animals will be monitored by vaginal smears and blood LH measurements...
  6. STUDY OF VAGINAL DANAZOL ON ENDOMETRIOSIS
    John Ziemniak; Fiscal Year: 1999
    ..Vaginal examination and vaginal smears will be done to record local effects...
  7. REPEAT MAMMOGRAPHY AMONG LOW INCOME AND MINORITY WOMEN
    Maria Fernandez; Fiscal Year: 2003
    ..g. stage of mammography adoption, self-efficacy, attitudes toward mammography, and perceived susceptibility to breast cancer). ..
  8. Liver Cancer Control Among North American Chinese
    Victoria Taylor; Fiscal Year: 2006
    ..If effective, our outreach intervention could be used by health care facilities and community organizations serving less acculturated Chinese in North America. ..
  9. Hepatitis B ESL Education for Chinese
    Victoria Taylor; Fiscal Year: 2009
    ..Our primary outcome will be HBV serologic testing. Knowledge about key hepatitis B facts will be examined as a secondary outcome. ..
  10. Cervical Cancer Control in Vietnamese Women
    Victoria Taylor; Fiscal Year: 2007
    ..abstract_text> ..
  11. DNA Methylation as a Risk Factor for Cervical Neoplasia
    Long Fu Xi; Fiscal Year: 2009
    ..Data from the proposed study will not only shed light on our understanding of the role of CpG methylation in development of cervical neoplasia but also help to better design future cervical cancer control programs. ..
  12. MOLECULAR EPIDEMIOLOGY OF PERSISTENT HPV INFECTION
    Eduardo Franco; Fiscal Year: 2003
    ..abstract_text> ..
  13. An Appalchian Cervical Cancer Prevention Project
    Nancy Schoenberg; Fiscal Year: 2007
    ..abstract_text> ..
  14. Urinary Symptoms in Adolescent Females: STI or UTI?
    Jill Huppert; Fiscal Year: 2004
    ..The findings of this study will strengthen the evidence base for symptom-based STI testing of SA adolescent females and will promote care that addresses both individual patient and public health needs. ..
  15. Human Papillovirus Testing in Adolescents
    Jessica Kahn; Fiscal Year: 2006
    ..Aim 5 To determine the cumulative prevalence and rates of persistence and regression of HPV infection, and correlation of HPV test results with cervicaI cytology, in the above sample of urban adolescent girls. ..
  16. Cancer Caregiving and the Stress Process
    Nancy Schoenberg; Fiscal Year: 2004
    ..abstract_text> ..
  17. EPIDEMIOLOGY OF HPV16/18 VARIANTS IN CERVICAL NEOPLASIA
    Long Fu Xi; Fiscal Year: 2003
    ..The proposed study is likely to make important contributions to our understanding of the role of HPV 16 and 18 variants in the pathogenesis of cervical cancer. ..
  18. Predicting Adherence to Follow up of Abnormal Pap Smears
    CARMEN RADECKI BREITKOPF; Fiscal Year: 2002
    ..By informing both clinicians and researchers who are involved with cervical cancer prevention, this research will ultimately reduce the morbidity and mortality due to this disease. ..
  19. Culture, Gender and Pap Smear Use among Latinas
    Israel De Alba; Fiscal Year: 2005
    ..The results of this study will lay the foundation for a future intervention aimed at preventing cervical cancer through the education of couples. ..
  20. Cervical Cancer Screening in Lesbians
    J Tracy; Fiscal Year: 2008
    ..unreadable] [unreadable] [unreadable] [unreadable]..
  21. NATURAL HISTORY OF HPV--INFECTION TO NEOPLASIA
    Anna Barbara Moscicki; Fiscal Year: 2004
    ..The understanding of both local and systemic immune responses to initial and subsequent HPV infections may be key in vaccine or therapeutic developments. ..
  22. HPV Type and Biological Potential of Cervical Lesions
    Rosemary Zuna; Fiscal Year: 2006
    ..Targeting the key features that identify high risk lesions could increase the specificity of cancer screening while reducing the burden of treating women whose lesions will not progress. ..
  23. Natural History of CIN2 in Adolescents
    Anna Barbara Moscicki; Fiscal Year: 2007
    ..S. and specifically assess how best to modify cytology-based screening, utilize HPV diagnostics, and tailor aoDrooriate follow-uo strategies for adolescents and vouna women diaanosed with CIN 2 ..
  24. Learner Verification of Cervical Cancer Education with Mexican Immigrant Women
    Jennifer Hunter; Fiscal Year: 2008
    ..unreadable] [unreadable] [unreadable]..
  25. Testing Pharmacological Therapies for Pregnant Smokers
    Kathryn Pollak; Fiscal Year: 2006
    ..Moreover, the study results have immediate potential to inform clinical recommendations for integrating nicotine replacement into prenatal care. ..
  26. Improving Patient Safety by Examining Pathology Errors
    Stephen Raab; Fiscal Year: 2006
    ..abstract_text> ..
  27. The Acquisition of Bacterial Vaginosis in Lesbians
    Jeanne Marrazzo; Fiscal Year: 2006
    ..Lesbian couples provide a unique opportunity to conduct comparative studies of vaginal microbial ecology in sex partners, and to directly analyze determinants of transmission. ..
  28. CCBAR Workshop 2006-2007
    STACY LINDAU; Fiscal Year: 2007
    ..unreadable] [unreadable] [unreadable]..
  29. International Collaborative HNC Research
    Elaine Smith; Fiscal Year: 2007
    ..This aim is to determine whether there is an easily administered, sensitive biomarker that can predict HPV-HR status in HNC tumors prior to therapy.. [unreadable] [unreadable] [unreadable]..
  30. Understanding Reversed Race/Ethnic Associations with Cancer Screening Tests
    William Rakowski; Fiscal Year: 2008
    ..Fifth, it will be possible to look for trends over time in the presence of reversals of association for repeat screening. [unreadable] [unreadable] [unreadable]..
  31. Cervical Cancer Prevention in Latina Immigrants
    Isabel C Scarinci; Fiscal Year: 2010
    ..Secondary outcome will include: changes in knowledge, attitudes, and beliefs regarding the relationship between the human papillomavirus (HPV) infection and cervical cancer. ..
  32. Transcripitonal and Genetic Profiles in HNSCCs
    Elaine Smith; Fiscal Year: 2008
    ..abstract_text> ..
  33. COOPERATIVE MULTI CENTER REPRODUCTIVE MEDICINE NETWORK
    Evan Myers; Fiscal Year: 2005
    ..abstract_text> ..
  34. VIOLENCE AND SPONTANEOUS ABORTION IN INNER CITY WOMEN
    Deborah Nelson; Fiscal Year: 2002
    ....
  35. GENETIC EPIDEMIOLOGY AND MECHANISMS IN ORAL CANCER
    Elaine Smith; Fiscal Year: 2003
    ..abstract_text> ..
  36. Diverse Screening Histories--Persons, Groups, Behaviors
    William Rakowski; Fiscal Year: 2005
    ..Mentored junior investigators will participate in these activities, as they develop their own programs of research. ..
  37. Using EE Video to Promote Cancer Screening in Thai Women
    Gail Love; Fiscal Year: 2005
    ..Results from this study will inform future video-based education efforts, particularly focused on small, "harder to reach" populations across the U.S. ..
  38. Understand Disparities in Cervical Cancer Survival
    Ann Coker; Fiscal Year: 2006
    ..abstract_text> ..
  39. WIH/Brown Epidemiology/Clinical Trials Training Program
    Lori Boardman; Fiscal Year: 2006
    ..This multidisciplinary program will provide a new cadre of ob/gyn investigators who will further the scientific database in reproductive health. ..
  40. Changes in the Cornified Cell Envelope in HPV Infection
    Darron Brown; Fiscal Year: 2006
    ..abstract_text> ..
  41. Protective Immune Responses in HIV-1 Exposed Infants
    Carey Farquhar; Fiscal Year: 2006
    ..Kreiss and John, will prepare her for the complex data analysis required by this study and contribute substantially to the development of her career as an independent clinical investigator. ..
  42. IMPACT OF RISK TALKS ON PATIENT COLORECTAL SCREENING
    Linda Larkey; Fiscal Year: 2004
    ..Research Question 1: Which source of cancer risk discussions will improve the rates of patient compliance with the recommended colorectal early detection tests more, physician or staff initiated? ..
  43. GLYCEMIC INDEX/GLYCEMIC LOAD AND BLOOD LIPIDS IN THE WHI
    James Shikany; Fiscal Year: 2004
    ..Existing WHI FFQs will then be reanalyzed to calculate each participant's mean dietary GI and GL. Existing blood glucose, insulin, and lipid data for these WHI participants will be used in the data analyses. ..
  44. Does Menopause Matter?
    Rachel Hess; Fiscal Year: 2008
    ..It will facilitate the candidate's transition to an independent health services researcher examining the impact of biologic and sociologic factors on HRQOL and HSU. [unreadable] [unreadable]..
  45. Recovery of RNA from Formalin-Fixed Tissues
    TIMOTHY O LEARY; Fiscal Year: 2007
    ..This knowledge should result in an ability to carry out genomic analysis on FFPE tissue, significantly expanding our capability to conduct genomic research and opening important new areas to practical investigation. ..
  46. Center for Healthy Native Communities
    Thomas Becker; Fiscal Year: 2008
    ..abstract_text> ..
  47. Early Diagnosis of Cervical Cancer
    SUBBI MATHUR; Fiscal Year: 2003
    ..We believe that serum IGF-II test could compliment the Pap test to reduce deaths by cervical cancer. ..
  48. Reducing Health Disparities: Survey Validation for Black, Latina and Arab Women
    Karen Patricia Williams; Fiscal Year: 2010
    ..This will be done by providing a baseline measure for cancer literacy in three groups of women, Black, Latina and Arab, who are disproportionately affected by breast and cervical cancer mortality. ..
  49. BREAST CANCER SURVIVORS, PHYSICAL ACTIVITY, AND QOL
    Karen Basen Engquist; Fiscal Year: 2002
    ..The information obtained in this pilot project will be used to propose a larger group randomized trial of the LPA intervention in the breast cancer survivor population. ..
  50. Clinical & Cost Effectiveness of HPV Vaccination in the US
    Sue Goldie; Fiscal Year: 2009
    ....
  51. Lymphoma in Autoimmune Disease: Consequence of Immune Suppression or Stimulation?
    Sasha Bernatsky; Fiscal Year: 2008
    ..Our proposed project will help identify patients at highest risk for lymphoma and provide guidance regarding initiation and maintenance of therapy to control SLE. [unreadable] [unreadable] [unreadable]..
  52. Prenatal Corticosteroid Impact on Hippocampus
    LIBOR VELISEK; Fiscal Year: 2004
    ..The data of this proposal will be critical for determining long-term adverse effects of multiple course prenatal corticosteroid therapy and for the ameliorating these effects in the offspring. ..
  53. Intermediate Outcomes of Hysterectomy and Alternatives
    Miriam Kuppermann; Fiscal Year: 2006
    ..abstract_text> ..
  54. Organized Self-Management Support for Chronic Depression
    Evette Ludman; Fiscal Year: 2005
    ....
  55. Advanced Reproductive Age and Environmental Health
    Stephanie Engel; Fiscal Year: 2007
    ..unreadable] [unreadable] [unreadable]..
  56. Promoting Postpartum Weight Loss in Overweight Women
    Truls Ostbye; Fiscal Year: 2007
    ..In addition, extended follow-up will enable evaluation of long-term benefits of the intervention for weight loss and maintenance. ..
  57. Depression Screening & Treatment in Ovarian Cancer
    Eileen Shinn; Fiscal Year: 2007
    ..Drs. Rehm and Taylor will co-supervise Dr. Shinn in the CBT administration. This intervention is innovative and has not been done before with any group of cancer patients, including ovarian cancer patients. ..
  58. Immune Responses in Genital Chlamydia Prior to Therapy
    WILLIAM GEISLER; Fiscal Year: 2005
    ..abstract_text> ..
  59. KAN-DO: A Family-Based Intervention to Prevent Childhood Obesity
    Truls Ostbye; Fiscal Year: 2010
    ..Participants will be surveyed at baseline (3 months postpartum), 12 and 24 months post-baseline. Extended follow-up will enable evaluation of long-term benefits, and if effective, the KAN-DO intervention can be disseminated broadly. ..
  60. Community Based Clinical Trials Education Program
    Georgia Sadler; Fiscal Year: 2006
    ..The clinical trials. infrastructure has had extensive revisions to allow for accurate endpoint assessment with future efforts. ..
  61. Fucosylated cell surface molecules in tumor invasion
    STEVEN DOMINO; Fiscal Year: 2005
    ..and in 1,2-dimethylhydrazine-induced tumors, in the presence and absence of cell surface alpha(1,2)fucose by crossing mice into the Fut1 and Fut2 null background. ..
  62. Economic Evaluation of Addiction Services
    JENNIFER RUGER; Fiscal Year: 2007
    ..unreadable] [unreadable] [unreadable] [unreadable]..
  63. Management of Vaginal Complaints: A Pilot Study within
    Matthew Anderson; Fiscal Year: 2006
    ..On the other hand, the trial may support a more limited approach that avoids a pelvic examination. This could result in substantial savings of health care dollars with equivalent clinical outcomes. [unreadable] [unreadable] [unreadable]..
  64. Effects of the Minimum Drinking Age on Mortality, Nonfatal Injury, and Crime
    Christopher Carpenter; Fiscal Year: 2009
    ..In so doing, this project will have the potential to reduce alcohol related harms experienced by youths. ..